Skip to main content
Figure 5 | Journal of Experimental & Clinical Cancer Research

Figure 5

From: Rapamycin potentiates cytotoxicity by docetaxel possibly through downregulation of Survivin in lung cancer cells

Figure 5

Combination treatment of rapamycin and docetaxel decreases phosphorylation of ERK in 95D cell lines. 95D cells were treated with 1 nM and 10 nM docetaxel alone, 10 nM and 20 nM rapamycin alone and a combination with 10 nM docetaxel and 20 nM rapamycin for 24 hr. After incubation, levels of ERK1/2 and p-ERK1/2 (phosphorylated Tyr204) were examined. Con: control, Rapa: rapamycin, DTX: docetaxel.

Back to article page